Dr. Ambroise Wonkam, director of genetic medicine at Johns Hopkins, has dedicated his career to studying genetic variation in African populations and its impact on conditions like sickle cell disease. He explains how African-specific genetic modifiers could unlock new treatments, not just for sickle cell patients, but for improving healthcare globally.